Technology-enabled Specialty Pharmacy Utilization of the Routine Assessment of Patient Index Data (RAPID3) to Monitor and Enhance Outcomes of Rheumatoid Arthritis (RA) Patient- A Retrospective Review

All Posts

Technology-enabled Specialty Pharmacy Utilization of the Routine Assessment of Patient Index Data (RAPID3) to Monitor and Enhance Outcomes of Rheumatoid Arthritis (RA) Patient- A Retrospective Review


Our CPS team returned from the NASP (National Association of Specialty Pharmacies) Annual Meeting in Washington D.C. where a CPS leader spoke on a panel with other industry experts on technology and how important interoperability and reporting is. This conference marked the first time ever that CPS submitted an abstract to the association and received approval to have a poster presentation at the conference. The poster was created based on a study that CPS completed on Rheumatoid Arthritis adherence and outcomes improvement. CPS received FIRST PLACE in the specialty pharmacy technology provided products and services group.  A HUGE CONGRATS and THANK YOU to our customers and team members that were involved in this study. The Poster Presentation is titled "Technology-enabled Specialty Pharmacy Utilization of the Routine Assessment of Patient Index Data (RAPID3) to Monitor and Enhance Outcomes of Rheumatoid Arthritis (RA) Patient- A Retrospective Review". 

 

If you would like more information on how your pharmacy can be a part of future outcomes studies, please contact us today.

 

 

 

Submit your contact information below to receive insights from our team of pharmacy solutions experts.